$263.00
Quantitative assay for measuring direct thrombin inhibitors (DTI), such as Dabigatran, Argatroban, and Hirudin, in human citrated plasma.
PRODUCT DESCRIPTION
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Quantitative assay for measuring direct thrombin inhibitors (DTI), such as Dabigatran, Argatroban, and Hirudin, in human citrated plasma, with a clotting method based on the inhibition of a constant and defined concentration of thrombin.
Quantitative assay for measuring direct thrombin inhibitors (DTI), such as Dabigatran, Argatroban, and Hirudin, in human citrated plasma.
PRODUCT CHARACTERISTICS
Total Assay Time: < 3 min
Detection Threshold: < 0.1 µg/mL
Dabigatran: < 20 ng/mL
Dynamic Range: 0 - 5 µg/mL
Dabigatran: < 50-500 ng/mL
Intra-Assay CV: < 4%
Inter-Assay CV: < 6%
Number of Tests (manual method): 3 x 10 Tests
PRODUCT COMPONENTS
R1: 3 x 1 mL Normal pooled citrated plasma.
R2: 3 x 1 mL Highly purified human calcium thrombin (α form).
Video of Product Components
PRODUCT APPLICATION
For the measurement of anti-thrombin activity and direct thrombin inhibitors such as Dabigatran, Argatroban, and Hirudin in research applications.
Associated calibrators and controls are available: Dabigatran Plasma Calibrators (Ref A222801-RUO and
A222901-RUO), Dabigatran Control Plasmas (Ref A224701-RUO and
A225001-RUO), Argatroban Plasma Calibrator (Ref ASC030K-RUO),
Argatroban Control Plasma (Ref ASC035K-RUO).
MSDS Documents
IFU Documents
